IBDEI35G ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52875,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 20-29% Body Surface
 ;;^UTILITY(U,$J,358.3,52875,1,4,0)
 ;;=4^L49.2
 ;;^UTILITY(U,$J,358.3,52875,2)
 ;;=^5009192
 ;;^UTILITY(U,$J,358.3,52876,0)
 ;;=L49.3^^243^2651^17
 ;;^UTILITY(U,$J,358.3,52876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52876,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 30-39% Body Surface
 ;;^UTILITY(U,$J,358.3,52876,1,4,0)
 ;;=4^L49.3
 ;;^UTILITY(U,$J,358.3,52876,2)
 ;;=^5009193
 ;;^UTILITY(U,$J,358.3,52877,0)
 ;;=L49.4^^243^2651^18
 ;;^UTILITY(U,$J,358.3,52877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52877,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 40-49% Body Surface
 ;;^UTILITY(U,$J,358.3,52877,1,4,0)
 ;;=4^L49.4
 ;;^UTILITY(U,$J,358.3,52877,2)
 ;;=^5009194
 ;;^UTILITY(U,$J,358.3,52878,0)
 ;;=L49.5^^243^2651^19
 ;;^UTILITY(U,$J,358.3,52878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52878,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 50-59% Body Surface
 ;;^UTILITY(U,$J,358.3,52878,1,4,0)
 ;;=4^L49.5
 ;;^UTILITY(U,$J,358.3,52878,2)
 ;;=^5009195
 ;;^UTILITY(U,$J,358.3,52879,0)
 ;;=L49.6^^243^2651^20
 ;;^UTILITY(U,$J,358.3,52879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52879,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 60-69% Body Surface
 ;;^UTILITY(U,$J,358.3,52879,1,4,0)
 ;;=4^L49.6
 ;;^UTILITY(U,$J,358.3,52879,2)
 ;;=^5009196
 ;;^UTILITY(U,$J,358.3,52880,0)
 ;;=L49.7^^243^2651^21
 ;;^UTILITY(U,$J,358.3,52880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52880,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 70-79% Body Surface
 ;;^UTILITY(U,$J,358.3,52880,1,4,0)
 ;;=4^L49.7
 ;;^UTILITY(U,$J,358.3,52880,2)
 ;;=^5009197
 ;;^UTILITY(U,$J,358.3,52881,0)
 ;;=L49.8^^243^2651^22
 ;;^UTILITY(U,$J,358.3,52881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52881,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 80-89% Body Surface
 ;;^UTILITY(U,$J,358.3,52881,1,4,0)
 ;;=4^L49.8
 ;;^UTILITY(U,$J,358.3,52881,2)
 ;;=^5009198
 ;;^UTILITY(U,$J,358.3,52882,0)
 ;;=L49.9^^243^2651^25
 ;;^UTILITY(U,$J,358.3,52882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52882,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ > 89% Body Surface
 ;;^UTILITY(U,$J,358.3,52882,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,52882,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,52883,0)
 ;;=Z65.5^^243^2651^26
 ;;^UTILITY(U,$J,358.3,52883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52883,1,3,0)
 ;;=3^Exposure to Disaster/War/Hostilities
 ;;^UTILITY(U,$J,358.3,52883,1,4,0)
 ;;=4^Z65.5
 ;;^UTILITY(U,$J,358.3,52883,2)
 ;;=^5063184
 ;;^UTILITY(U,$J,358.3,52884,0)
 ;;=Z77.22^^243^2651^27
 ;;^UTILITY(U,$J,358.3,52884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52884,1,3,0)
 ;;=3^Exposure to/Contact w/ Environmental Tobacco Smoke
 ;;^UTILITY(U,$J,358.3,52884,1,4,0)
 ;;=4^Z77.22
 ;;^UTILITY(U,$J,358.3,52884,2)
 ;;=^5063324
 ;;^UTILITY(U,$J,358.3,52885,0)
 ;;=L30.9^^243^2651^5
 ;;^UTILITY(U,$J,358.3,52885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52885,1,3,0)
 ;;=3^Eczema,Unspec
 ;;^UTILITY(U,$J,358.3,52885,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,52885,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,52886,0)
 ;;=L23.9^^243^2651^2
 ;;^UTILITY(U,$J,358.3,52886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52886,1,3,0)
 ;;=3^Eczema,Allergic Contact,Unspec
 ;;^UTILITY(U,$J,358.3,52886,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,52886,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,52887,0)
 ;;=L20.82^^243^2651^3
 ;;^UTILITY(U,$J,358.3,52887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52887,1,3,0)
 ;;=3^Eczema,Flexural
 ;;^UTILITY(U,$J,358.3,52887,1,4,0)
 ;;=4^L20.82
